GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant ...

The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...

The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer.The indication ...

Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

If you are one of those who pop painkillers all too often, then you might be raising your risk of heart attack and heart ...

In England, about 600 people will benefit from the daily pill that helps treat lung cancer as it becomes routinely available on the NHS.

A new treatment for the most common form of breast cancer has boosted cure rates in a major international trial.

Approval is based on results from the TROPION-Breast01 Phase III trial, in which Datroway demonstrated a significant ...

The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...

Turmeric's active compound, curcumin, is a potent anti-inflammatory and antioxidant that can help with conditions like ...